Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Current Value
$7.721 Year Return
Current Value
$7.721 Year Return
Market Cap
$483.43M
P/E Ratio
-7.82
1Y Stock Return
-8.71%
1Y Revenue Growth
16.14%
Dividend Yield
0.00%
Price to Book
4.6
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Stifel 2024 Healthcare Conference
Finnhub
LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical...
Yahoo
Treace Medical Concepts ( NASDAQ:TMCI ) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1m (up 11% from...
Yahoo
Q3 2024 Treace Medical Concepts Inc Earnings Call
Yahoo
Treace Medical Concepts Inc (TMCI) reports an 11% revenue increase and unveils new technologies amid ongoing market challenges.
Yahoo
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 7.41% and 3.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ELV | 0.02% | $91.42B | -16.23% | 1.61% |
IMRN | 0.04% | $10.31M | -5.04% | 0.00% |
RNG | -0.15% | $3.22B | +23.39% | 0.00% |
ZTO | -0.16% | $12.58B | -4.71% | 4.73% |
SU | 0.20% | $52.05B | +23.58% | 3.92% |
AIZ | 0.21% | $11.24B | +33.00% | 1.31% |
AGX | 0.22% | $2.01B | +224.91% | 0.85% |
MPC | 0.24% | $51.04B | +7.57% | 1.57% |
XBIO | 0.25% | $6.01M | +21.36% | 0.00% |
CEG | -0.25% | $73.37B | +91.48% | 0.59% |
FTI | -0.29% | $12.24B | +36.61% | 0.87% |
GD | 0.29% | $77.26B | +14.02% | 1.98% |
AON | 0.29% | $82.00B | +16.33% | 0.70% |
WHLM | 0.29% | $17.64M | -29.34% | 0.00% |
MOH | -0.30% | $16.16B | -21.56% | 0.00% |
PRPO | -0.35% | $9.10M | -13.65% | 0.00% |
APEI | -0.35% | $339.36M | +232.64% | 0.00% |
FATBB | 0.37% | $81.94M | -12.91% | 11.69% |
TCTM | -0.41% | $8.10M | -42.99% | 0.00% |
TRV | -0.42% | $58.86B | +48.10% | 1.59% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DV | 62.96% | $3.26B | -37.48% | 0.00% |
QLYS | 55.53% | $5.18B | -21.75% | 0.00% |
TRIP | 55.07% | $1.87B | -29.46% | 0.00% |
RPD | 54.27% | $2.47B | -24.37% | 0.00% |
ALIT | 49.05% | $4.16B | +4.01% | 0.00% |
NATR | 47.80% | $295.06M | -7.42% | 0.00% |
INSP | 47.68% | $5.28B | +27.64% | 0.00% |
RRR | 46.84% | $2.95B | +13.51% | 2.03% |
NRC | 46.33% | $442.05M | -55.00% | 2.56% |
GDOT | 45.03% | $573.37M | +28.74% | 0.00% |
ZI | 44.89% | $3.40B | -28.47% | 0.00% |
LZ | 43.88% | $1.30B | -33.57% | 0.00% |
VPG | 43.57% | $279.20M | -30.23% | 0.00% |
MCFT | 43.49% | $344.65M | -0.29% | 0.00% |
KRNT | 43.46% | $1.48B | +73.34% | 0.00% |
GO | 42.91% | $1.81B | -34.42% | 0.00% |
EYE | 42.59% | $888.30M | -42.18% | 0.00% |
RDUS | 42.29% | $492.65M | -31.07% | 4.30% |
CYRX | 41.48% | $342.80M | -48.82% | 0.00% |
AMPL | 40.71% | $1.34B | -0.66% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRCT | -41.41% | $1.12B | -19.90% | 1.91% |
ELAN | -23.02% | $6.58B | +12.99% | 0.00% |
TEVA | -21.95% | $19.05B | +81.34% | 0.00% |
ASC | -21.18% | $517.16M | -7.62% | 8.45% |
KD | -21.11% | $6.51B | +55.09% | 0.00% |
OXBR | -19.49% | $19.05M | +178.18% | 0.00% |
LPX | -17.71% | $7.84B | +85.45% | 0.70% |
RNR | -16.49% | $13.74B | +23.09% | 0.58% |
ACGL | -15.36% | $36.00B | +16.84% | 0.00% |
NNVC | -14.53% | $19.66M | +25.69% | 0.00% |
RGA | -14.33% | $14.97B | +41.90% | 1.52% |
MYGN | -14.26% | $1.37B | -14.19% | 0.00% |
HUSA | -14.05% | $16.69M | -11.56% | 0.00% |
VZIO | -13.98% | $2.29B | +67.76% | 0.00% |
CME | -13.47% | $82.76B | +9.21% | 1.98% |
MCK | -12.92% | $78.15B | +35.51% | 0.42% |
CBOE | -12.46% | $21.46B | +15.84% | 1.11% |
GMED | -12.43% | $11.35B | +81.49% | 0.00% |
ALL | -12.39% | $52.06B | +45.67% | 1.85% |
PGR | -11.94% | $149.10B | +57.29% | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | -0.26% | $120.27M | 0.28% |
JBBB | 0.66% | $1.26B | 0.49% |
SOYB | -0.76% | $27.32M | 0.22% |
COMT | -0.84% | $829.06M | 0.48% |
SGOV | 0.88% | $27.53B | 0.09% |
TBLL | 0.97% | $1.92B | 0.08% |
FMF | 0.98% | $244.61M | 0.95% |
GSG | -1.28% | $914.42M | 0.75% |
DBA | 1.36% | $755.88M | 0.93% |
PDBC | 1.42% | $4.40B | 0.59% |
MINT | -1.53% | $11.62B | 0.35% |
XHLF | 1.56% | $874.27M | 0.03% |
DBC | 1.65% | $1.39B | 0.87% |
CLOI | 1.81% | $715.40M | 0.4% |
CORN | 1.95% | $61.12M | 0.2% |
IAK | -2.00% | $760.79M | 0.39% |
SMB | 2.65% | $266.77M | 0.07% |
UNG | -2.67% | $908.80M | 1.06% |
KIE | 2.78% | $956.77M | 0.35% |
XBIL | 2.88% | $637.70M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 57.72% | $213.41M | 0.35% |
RSPA | 49.40% | $273.87M | 0% |
IWM | 48.30% | $75.73B | 0.19% |
IWO | 48.22% | $12.56B | 0.24% |
VTWO | 48.00% | $12.38B | 0.1% |
PSC | 47.98% | $702.17M | 0.38% |
IJT | 47.96% | $6.64B | 0.18% |
SLYG | 47.61% | $3.69B | 0.15% |
SMLF | 47.53% | $1.44B | 0.15% |
VIOO | 47.53% | $3.12B | 0.1% |
XSMO | 47.40% | $1.25B | 0.39% |
IWC | 47.26% | $933.99M | 0.6% |
ESML | 47.14% | $1.90B | 0.17% |
SPSM | 47.11% | $12.72B | 0.03% |
IJR | 47.08% | $90.05B | 0.06% |
GSSC | 47.07% | $529.86M | 0.2% |
IJJ | 47.02% | $8.03B | 0.18% |
EZM | 46.60% | $823.84M | 0.38% |
FYX | 46.58% | $959.00M | 0.6% |
EES | 46.55% | $668.71M | 0.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -39.02% | $388.04M | 1.43% |
VIXY | -18.12% | $195.31M | 0.85% |
USDU | -15.82% | $201.97M | 0.5% |
FLRT | -15.29% | $401.26M | 0.6% |
TAIL | -12.99% | $67.98M | 0.59% |
KMLM | -11.31% | $353.87M | 0.9% |
CTA | -11.22% | $350.27M | 0.78% |
JUCY | -11.06% | $324.29M | 0.6% |
UUP | -10.38% | $309.25M | 0.77% |
MSOS | -9.59% | $632.80M | 0.83% |
TPMN | -9.17% | $40.60M | 0.65% |
DBO | -8.14% | $217.57M | 0.77% |
AGZD | -7.19% | $142.76M | 0.23% |
EQLS | -6.96% | $76.08M | 1% |
TBIL | -6.56% | $4.38B | 0.15% |
HIGH | -6.16% | $302.78M | 0.51% |
DBMF | -5.59% | $1.02B | 0.85% |
BOXX | -5.24% | $4.43B | 0.1949% |
DBE | -4.39% | $50.13M | 0.77% |
KRBN | -3.65% | $242.47M | 0.85% |